Better Choice Company Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Private Placement	IPO	June 2020 Notes	November 2019 Notes, Seller Notes and ABG Notes	ABL Facility	Series F Preferred Stock	Series E Preferred Stock	Common Stock	Common Stock Private Placement	Common Stock IPO	Common Stock Series F Preferred Stock	Convertible Preferred Stock Series F Preferred Stock	Additional Paid-In Capital	Additional Paid-In Capital Private Placement	Additional Paid-In Capital IPO	Additional Paid-In Capital June 2020 Notes	Additional Paid-In Capital November 2019 Notes, Seller Notes and ABG Notes	Additional Paid-In Capital ABL Facility	Additional Paid-In Capital Series F Preferred Stock	Accumulated Deficit	Accumulated Deficit Series F Preferred Stock
Beginning balance (in shares) at Dec. 31, 2019									7,996,232
Beginning balance at Dec. 31, 2019	$ (7,071)								$ 8					$ 194,190							$ (201,269)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares pursuant to private placement, IPO and Exchange Transaction (in shares)									51,440				21,702
Shares pursuant to private placement, IPO and Exchange Transaction	500						$ 13,916							500						$ 8,501		$ 5,415
Share-based compensation (in shares)									75,993
Share-based compensation	8,940								$ 1					8,939
Shares and warrants issued to third party for contract termination (in shares)									12,120
Shares and warrants issued to third-party for contract termination	198													198
Shares issued to third-parties for services	1,372													1,372
Shares issued to third parties for services (in shares)									193,333				100
Warrants issued to third-parties for services	10,132													10,132
Warrants issued in connection with June 2020 Notes				$ 337		$ 230											$ 337		$ 230
Beneficial conversion feature of June 2020 Notes				$ 1,163													$ 1,163
Modification of conversion feature for November 2019, Seller, and ABG Notes					$ 528													$ 528
Warrant modifications	43													43
Warrant exercises	1,048													1,048
Warrant exercises (in shares)									306,282
Conversion of Notes and Series F shares (in shares)												16,000	(48)
Net income (loss) available to common stockholders	(59,438)																				(59,438)
Beneficial conversion feature of Series F shares																				5,349		$ (5,349)
Ending balance at Dec. 31, 2020	(28,102)								$ 9				$ 0	232,530							(260,641)
Ending balance (in shares) at Dec. 31, 2020									8,651,400				21,754
Beginning balance (in shares) at Dec. 31, 2019								1,387,378
Beginning balance at Dec. 31, 2019								$ 10,566
Redeemable Series E Convertible Preferred Stock
Shares issued pursuant to Series F Private Placement and Exchange Transactions (in shares)								(1,387,378)
Shares issued pursuant to Series F Private Placement and Exchange Transaction								$ (10,566)
Ending balance (in shares) at Dec. 31, 2020								0
Ending balance at Dec. 31, 2020								$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares pursuant to private placement, IPO and Exchange Transaction (in shares)										546,733	8,000,000
Shares pursuant to private placement, IPO and Exchange Transaction		$ 4,072	$ 36,085							$ 1	$ 8				$ 4,071	$ 36,077
Share-based compensation (in shares)									17,537
Share-based compensation	4,140													4,140
Shares issued to third-parties for services	46													46
Shares issued to third parties for services (in shares)									5,000
Warrant modifications	0													402							(402)
Warrant exercises	1,685													1,685
Warrant exercises (in shares)									380,716
Conversion of Series F shares to common stock							$ 0					$ 7								$ (7)
Conversion of Series F shares to common stock (in shares)												7,251,205	(21,754)
Conversion of Notes and Series F shares (in shares)									4,732,420
Conversion of Notes and Series F shares	21,776								$ 5					21,771
Shares issued in lieu of fractional shares due to reverse stock split (in shares)									1,081
Reclassification of warrant liability to equity	$ 16,387													16,387
Share repurchases (in shares)	(439,725)								(439,725)
Share repurchases	$ (1,601)								$ (1)												(1,600)
Net income (loss) available to common stockholders	3,387																				3,387
Ending balance at Dec. 31, 2021	$ 57,875								$ 29				$ 0	$ 317,102							$ (259,256)
Ending balance (in shares) at Dec. 31, 2021									29,146,367				0